Crossmark

High-dose rate brachytherapy as monotherapy in prostate cancer: A systematic review of its safety and efficacy

Crossref DOI link: https://doi.org/10.1016/j.acuroe.2016.12.001

Published Print: 2017-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Sánchez-Gómez, L.M.

Polo-deSantos, M.

Rodríguez-Melcón, J.I.

Angulo, J.C.

Luengo-Matos, S.
License Information

Text and Data Mining valid from 2017-03-01
More Information

This article is maintained by: Elsevier

Article Title: High-dose rate brachytherapy as monotherapy in prostate cancer: A systematic review of its safety and efficacy

Journal Title: Actas Urológicas Españolas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.acuroe.2016.12.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.acuro.2016.06.001

Content Type: article

Copyright: © 2016 AEU. Published by Elsevier España, S.L.U. All rights reserved.